$CRNX news
The latest CRNX stock news: headlines, filings, AI summaries and sentiment for $CRNX, updated around the clock.
- Vertex Pharmaceuticals Expands Beyond Cystic Fibrosis at Cantor Conference
- Vertex Acquires Crinetics in $10 Billion Deal for Expansion into Endocrinology
- Crinetics Pharmaceuticals, Inc. - 8-K Filing
- Crinetics Pharmaceuticals, Inc. - 8-K Filing
- Vertex Acquires Crinetics for $10 Billion; Viking Therapeutics Seen as Potential Next Target
- Vertex Pharmaceuticals Acquires Crinetics in $10 Billion Deal at High Premium
- Vertex Pharmaceuticals Acquires Crinetics Pharmaceuticals for $10 Billion
- Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals in $85 Per Share Cash Deal
- Law Firm Investigates Potential Shareholder Rights Violations in CRNX, VEEE, and ESI Transactions
- Vertex Pharmaceuticals Agrees to Acquire Crinetics Pharmaceuticals in $10 Billion Deal at Over 100% Premium
- Vertex Agrees to Pay Over $10 Billion for Crinetics Pharmaceuticals at a Premium
- Vertex Pharmaceuticals Announces $10 Billion Acquisition of Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Stock Surges Nearly 100% on Acquisition by Vertex
- Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion
- Crinetics Pharmaceuticals, Inc. - 8-K Filing
- Crinetics Pharmaceuticals Stock Surges Nearly 100% After Acquisition by Vertex Pharmaceuticals
- Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion
- Vertex Pharmaceuticals Acquires Crinetics for $10 Billion at 102% Premium
- Crinetics Pharmaceuticals Shares Surge Over 99% on $10 Billion Acquisition Deal with Vertex
- Vertex to Acquire Crinetics for $10 Billion with a 102% Premium
- Vertex Pharmaceuticals Acquires Crinetics for $10 Billion to Expand Rare-Disease Portfolio
- Vertex Pharmaceuticals Acquires Crinetics for $10 Billion
- CRNX, RIVN, DOCN Among Biggest Stock Movers on Tuesday
- Stocks Making Significant Premarket Moves: Fiserv, Crinetics Pharmaceuticals, Micron and Others
- Crinetics Pharmaceuticals, Inc. - 8-K Filing
- Analyst Updates on Crinetics Pharmaceuticals Following PALSONIFY Rollout
- Hedge Fund ADAR1 Capital Invests $37 Million in Crinetics Pharmaceuticals
- Crinetics (CRNX) Reports First Quarter 2026 Earnings and Business Update
- Crinetics Pharmaceuticals, Inc. - 10-Q Filing
- Crinetics Pharmaceuticals, Inc. - 8-K Filing